Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Meignan

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2010
Interim PET in lymphoma: a step towards standardizationMichel Meignan
Blood|August 22, 2015
Quantitative FDG-PET: a new biomarker in PMBCLMichel Meignan
Leukemia & Lymphoma|October 8, 2013
Reporting interim positron emission tomography in diffuse large B-cell lymphoma: the Zeno's paradoxMichel Meignan
The Lancet. Haematology|October 4, 2016
High-risk interim PET negative patients in Hodgkin's lymphomaMichel Meignan
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2014
Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cellsMichel Meignan
Hematological Oncology|June 11, 2015
VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysisMichel Meignan
Leukemia & Lymphoma|June 23, 2009
Report on the First International Workshop on Interim-PET-Scan in LymphomaMichel Meignan, Andrea Gallamini, Michel Meignan, et al.
Blood|June 20, 2020
ΔSUVmax for interim PET in DLBCL: old is newMichel Meignan, Andrea Gallamini
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2018
Deauville score: the Phoenix rising from ashesEgesta Lopci, Michel Meignan
PET Clinics|November 19, 2019
Current Evidence on PET Response Assessment to Immunotherapy in LymphomasEgesta Lopci, Michel Meignan
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
European Journal of Nuclear Medicine and Molecular Imaging|July 24, 2010
Interim PET in lymphoma: a step towards standardizationMichel Meignan
Blood|August 22, 2015
Quantitative FDG-PET: a new biomarker in PMBCLMichel Meignan
Leukemia & Lymphoma|October 8, 2013
Reporting interim positron emission tomography in diffuse large B-cell lymphoma: the Zeno's paradoxMichel Meignan
The Lancet. Haematology|October 4, 2016
High-risk interim PET negative patients in Hodgkin's lymphomaMichel Meignan
European Journal of Nuclear Medicine and Molecular Imaging|June 8, 2014
Baseline metabolic tumour volume in Hodgkin lymphoma: the prognostic value of accessory cellsMichel Meignan
Hematological Oncology|June 11, 2015
VI. FDG-PET as a biomarker in lymphoma: from qualitative to quantitative analysisMichel Meignan
Leukemia & Lymphoma|June 23, 2009
Report on the First International Workshop on Interim-PET-Scan in LymphomaMichel Meignan, Andrea Gallamini, Michel Meignan, et al.
Blood|June 20, 2020
ΔSUVmax for interim PET in DLBCL: old is newMichel Meignan, Andrea Gallamini
European Journal of Nuclear Medicine and Molecular Imaging|November 16, 2018
Deauville score: the Phoenix rising from ashesEgesta Lopci, Michel Meignan
PET Clinics|November 19, 2019
Current Evidence on PET Response Assessment to Immunotherapy in LymphomasEgesta Lopci, Michel Meignan
Pageof 13